Y-mAbs Therapeutics (YMAB) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 1 Phase 1[2].
No Form 4 insider filings for YMAB were recorded at the SEC in the past 30 days[4].
Y-mAbs Therapeutics (YMAB) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 1 Phase 1[2].
No Form 4 insider filings for YMAB were recorded at the SEC in the past 30 days[4].